Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network

Interleukins, a diverse family of cytokines produced by various cells, play crucial roles in immune responses, immunoregulation, and a wide range of physiological and pathological processes. In the context of megakaryopoiesis, thrombopoiesis, and platelet function, interleukins have emerged as key r...

Full description

Bibliographic Details
Main Authors: Miao Huang, Long Wang, Qianhui Zhang, Ling Zhou, Rui Liao, Anguo Wu, Xinle Wang, Jiesi Luo, Feihong Huang, Wenjun Zou, Jianming Wu
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/17/1/109
_version_ 1797342824715255808
author Miao Huang
Long Wang
Qianhui Zhang
Ling Zhou
Rui Liao
Anguo Wu
Xinle Wang
Jiesi Luo
Feihong Huang
Wenjun Zou
Jianming Wu
author_facet Miao Huang
Long Wang
Qianhui Zhang
Ling Zhou
Rui Liao
Anguo Wu
Xinle Wang
Jiesi Luo
Feihong Huang
Wenjun Zou
Jianming Wu
author_sort Miao Huang
collection DOAJ
description Interleukins, a diverse family of cytokines produced by various cells, play crucial roles in immune responses, immunoregulation, and a wide range of physiological and pathological processes. In the context of megakaryopoiesis, thrombopoiesis, and platelet function, interleukins have emerged as key regulators, exerting significant influence on the development, maturation, and activity of megakaryocytes (MKs) and platelets. While the therapeutic potential of interleukins in platelet-related diseases has been recognized for decades, their clinical application has been hindered by limitations in basic research and challenges in drug development. Recent advancements in understanding the molecular mechanisms of interleukins and their interactions with MKs and platelets, coupled with breakthroughs in cytokine engineering, have revitalized the field of interleukin-based therapeutics. These breakthroughs have paved the way for the development of more effective and specific interleukin-based therapies for the treatment of platelet disorders. This review provides a comprehensive overview of the effects of interleukins on megakaryopoiesis, thrombopoiesis, and platelet function. It highlights the potential clinical applications of interleukins in regulating megakaryopoiesis and platelet function and discusses the latest bioengineering technologies that could improve the pharmacokinetic properties of interleukins. By synthesizing the current knowledge in this field, this review aims to provide valuable insights for future research into the clinical application of interleukins in platelet-related diseases.
first_indexed 2024-03-08T10:38:47Z
format Article
id doaj.art-c679079971024a58aecc38e29fcddf35
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-08T10:38:47Z
publishDate 2024-01-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-c679079971024a58aecc38e29fcddf352024-01-26T18:06:05ZengMDPI AGPharmaceuticals1424-82472024-01-0117110910.3390/ph17010109Interleukins in Platelet Biology: Unraveling the Complex Regulatory NetworkMiao Huang0Long Wang1Qianhui Zhang2Ling Zhou3Rui Liao4Anguo Wu5Xinle Wang6Jiesi Luo7Feihong Huang8Wenjun Zou9Jianming Wu10State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaDepartment of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, ChinaDepartment of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, ChinaDepartment of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou 646000, ChinaState Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, ChinaDepartment of Physiology, School of Basic Medical Sciences, Southwest Medical University, Luzhou 646000, ChinaInterleukins, a diverse family of cytokines produced by various cells, play crucial roles in immune responses, immunoregulation, and a wide range of physiological and pathological processes. In the context of megakaryopoiesis, thrombopoiesis, and platelet function, interleukins have emerged as key regulators, exerting significant influence on the development, maturation, and activity of megakaryocytes (MKs) and platelets. While the therapeutic potential of interleukins in platelet-related diseases has been recognized for decades, their clinical application has been hindered by limitations in basic research and challenges in drug development. Recent advancements in understanding the molecular mechanisms of interleukins and their interactions with MKs and platelets, coupled with breakthroughs in cytokine engineering, have revitalized the field of interleukin-based therapeutics. These breakthroughs have paved the way for the development of more effective and specific interleukin-based therapies for the treatment of platelet disorders. This review provides a comprehensive overview of the effects of interleukins on megakaryopoiesis, thrombopoiesis, and platelet function. It highlights the potential clinical applications of interleukins in regulating megakaryopoiesis and platelet function and discusses the latest bioengineering technologies that could improve the pharmacokinetic properties of interleukins. By synthesizing the current knowledge in this field, this review aims to provide valuable insights for future research into the clinical application of interleukins in platelet-related diseases.https://www.mdpi.com/1424-8247/17/1/109interleukinsmegakaryopoiesisthrombopoiesisbioengineering
spellingShingle Miao Huang
Long Wang
Qianhui Zhang
Ling Zhou
Rui Liao
Anguo Wu
Xinle Wang
Jiesi Luo
Feihong Huang
Wenjun Zou
Jianming Wu
Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network
Pharmaceuticals
interleukins
megakaryopoiesis
thrombopoiesis
bioengineering
title Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network
title_full Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network
title_fullStr Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network
title_full_unstemmed Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network
title_short Interleukins in Platelet Biology: Unraveling the Complex Regulatory Network
title_sort interleukins in platelet biology unraveling the complex regulatory network
topic interleukins
megakaryopoiesis
thrombopoiesis
bioengineering
url https://www.mdpi.com/1424-8247/17/1/109
work_keys_str_mv AT miaohuang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT longwang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT qianhuizhang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT lingzhou interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT ruiliao interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT anguowu interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT xinlewang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT jiesiluo interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT feihonghuang interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT wenjunzou interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork
AT jianmingwu interleukinsinplateletbiologyunravelingthecomplexregulatorynetwork